Selected article for: "antibody response and second dose"

Author: Mazzola, Alessandra; Todesco, Eve; Drouin, Sarah; Hazan, Fanny; Marot, Stéphane; Thabut, Dominique; Varnous, Shaida; Soulié, Cathia; Barrou, Benoît; Marcelin, Anne-Geneviève; Conti, Filomena
Title: Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients
  • Cord-id: aktlenxg
  • Document date: 2021_6_24
  • ID: aktlenxg
    Snippet: A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant recipients without previous coronavirus disease 2019 (COVID-19). No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the 2 doses. Our data suggest to change the vaccine strategy.
    Document: A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant recipients without previous coronavirus disease 2019 (COVID-19). No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the 2 doses. Our data suggest to change the vaccine strategy.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date